Cargando…
VEGFR-2: One of Pioglitazone’s Signaling Pathways in the Heart
Autores principales: | Minicucci, Marcos Ferreira, Zornoff, Leonardo Antonio Mamede |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cardiologia - SBC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122901/ https://www.ncbi.nlm.nih.gov/pubmed/30183983 http://dx.doi.org/10.5935/abc.20180147 |
Ejemplares similares
-
Is There a Role For Whole Body Vibration in Protecting Cardiovascular
Disease?
por: Zornoff, Leonardo, et al.
Publicado: (2019) -
Obesity: A Growing Multifaceted Problem
por: Azevedo, Paula S., et al.
Publicado: (2015) -
Pioglitazone Induces Cardiomyocyte Apoptosis and Inhibits
Cardiomyocyte Hypertrophy Via VEGFR-2 Signaling Pathway
por: Zhong, Wenliang, et al.
Publicado: (2018) -
The Role of Sympathetic System as a Therapeutic Option in the
Ischemia/Reperfusion Injury
por: Polegato, Bertha F., et al.
Publicado: (2019) -
Jaboticaba (Myrciaria jaboticaba) Attenuates Ventricular Remodeling after Myocardial Infarction in Rats
por: da Silva, Renata Candido, et al.
Publicado: (2022)